世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039626

肝炎診断検査市場:規模、シェア、動向分析レポート、およびセグメント予測、2024〜2030

Grand View Research Inc.

Hepatitis Diagnostic Test Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2024- 2030

発刊日 2024/09

言語英語

体裁PDF/100ページ

ライセンス/価格100ページ

0000039626

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

肝炎診断検査の市場規模、シェア、動向分析レポート:検査別 (血液検査、画像検査、肝生検)、技術別 (ELISA、迅速診断検査、PCR)、最終用途別、地域別、セグメント予測、2024-2030

レポートの概要

世界の肝炎診断市場規模は2023年に38億2000万ドルと評価され、2024年から2030年にかけて6.5%のCAGR)で成長ると予測されます。

肝炎の分子診断の導入と意識の高まりが、予測期間における肝炎診断検査の重要性を推進しています。成人と子供におけるB型およびC型肝炎の症例の増加により、診断ソリューションの需要が必要になっています。例えば、2023年には、世界中で青年や小児の慢性C型肝炎の症例が300万人以上と推定されています。これにより、ウイルス感染の治療と診断に対する大きなニーズが生まれました。WHOは、一般の人々がウイルス性肝炎を理解し、予防措置に従うように教育するための意識向上キャンペーンを実施しています。

レポート詳細

目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Hepatitis Diagnostic Test Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Hepatitis Diagnostic Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining Power of the Suppliers
3.4.1.2. Bargaining Power of the Buyers
3.4.1.3. Threats of Substitution
3.4.1.4. Threats From New Entrants
3.4.1.5. Competitive Rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological Landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape

Chapter 4. Hepatitis Diagnostic Test Market: Test Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Hepatitis Diagnostic Test Market: Test Movement Analysis, USD Million, 2023 & 2030
4.3. Blood Tests
4.3.1. Blood Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.1. Liver Function Tests
4.3.1.1.1. Liver Function Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.2. Immunoassays
4.3.1.2.1. Immunoassays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.3. Nucleic Acid Tests
4.3.1.3.1. Nucleic Acid Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Imaging Tests
4.4.1. Imaging Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Liver Biopsy
4.5.1. Liver Biopsy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Hepatitis Diagnostic Test Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Hepatitis Diagnostic Market: Technology Movement Analysis, USD Million, 2023 & 2030
5.3. Enzyme-Linked immunosorbent assay (ELISA)
5.3.1. ELISA Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Rapid Diagnostic Test
5.4.1. Rapid Diagnostic Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Polymerase Chain Reaction (PCR)
5.5.1. Polymerase Chain Reaction (PCR) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Isothermal Nucleic Acid Amplification Technology (INAAT)
5.6.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Vision Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Hepatitis Diagnostic Test Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Hepatitis Diagnostic Market: End Use Movement Analysis, USD Million, 2023 & 2030
6.3. Hospitals and Diagnostics Labs
6.3.1. Hospitals and Diagnostics Lab Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Blood Banks
6.4.1. Blood Banks Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Hepatitis Diagnostic Test Market: Regional Estimates & Trend Analysis
7.1. Hepatitis Diagnostic Test Market Share, By Region, 2023 & 2030, USD Million
7.2. North America
7.2.1. North America Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Spain
7.3.5.1. Spain Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Demark
7.3.6.1. Denmark Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Sweden
7.3.7.1. Sweden Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Norway
7.3.8.1. Norway Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. South Africa
7.6.4.1. South Africa Hepatitis Diagnostic Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Abbott Laboratories
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Bio-Rad Laboratories Inc
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. BioMerieux SA
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. F. Hoffmann-La Roche AG
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Siemens Healthineers
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Diasorin S.p.A
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Qaigen
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Sysmex Corporation
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. VWR International, LLC
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Hologic Inc
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives

この商品のレポートナンバー

0000039626

TOP